Latest News
Datasea Stock Surges 115% on AI Service Launch, Revenue Claims Questioned
Datasea Intelligent Technology shares soared 115% after five clients started receiving AI-agent marketing services. The company's $89.4 million figure is an annualized ceiling, not actual revenue.
Nokia ADRs Jump 4.4% as Microsoft Fabric Integration Aims to Automate Telecom Networks
Nokia ADRs climbed 4.4% after announcing a Microsoft Fabric-based data layer for telecom automation. The move expands Nokia's AI exposure but lacks disclosed contract values.
Proposed A$858 Road Levy Could Reshape Australia's Vehicle Market
A proposed Australian road-user charge of A$858 for a typical vehicle could shift buyer preferences and affect stocks like Eagers Automotive and Lindsay Australia.
Australia's Debt Relief Hinges on Productivity Rebound
Australia's $500B debt improvement rests on 1.2% productivity growth; drop to 0.8% and savings vanish. Treasury's report due Monday.
Stellantis Brampton Exit Faces Ottawa Scrutiny as Shares Recover
Stellantis's Brampton plant sale faces a new hurdle as Ottawa reviews its funding commitments, even as shares rebound 3.8% from a 52-week low.
Pending Home Sales Inch Up in August, Annual Decline Persists
Pending home sales edged up 0.3% in August, but remain 4.7% below last year. Homebuilder ETFs (ITB, XHB) dipped slightly after the data release.
Live Nation's DOJ Settlement Faces Judicial Scrutiny; $450M Accrual Not Final
Live Nation's proposed DOJ settlement faces a court test as rivals and states object. The $450M accrual isn't a ceiling, with state trial verdict pending.
PGA Tour Finalizes 2028 Two-Tier Structure, 90 Cards Define New Era
PGA Tour finalizes 2028 two-tier system: 90 cards retained, 20 promotions. New structure aims to boost media value, with $3B investment from Strategic Sports Group.
DAIC Stock Surges 176% on Envoy Acquisition Deal
DAIC stock soared 176% after CID HoldCo announced plans to acquire Envoy Technologies in a complex deal involving preferred shares and a change of control.
Aethlon Medical Soars 467% on Merger, But Real Value Is $16.5M
Aethlon Medical (AEMD) skyrocketed 467% after announcing a merger with North Immunology, but the deal values legacy shareholders at $16.5M, not the $346.5M combined figure.
CoreWeave's Dual Financing Move Pressures Shares
CoreWeave shares slipped 2.2% after the company unveiled a $3 billion convertible note offering and a 35 million-share ATM program, as investors weighed dilution against growth prospects.